Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 112
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Exp Dermatol ; 26(3): 242-248, 2017 03.
Artigo em Inglês | MEDLINE | ID: mdl-27621222

RESUMO

Age spots, also called solar lentigines and lentigo senilis, are light brown to black pigmented lesions of various sizes that typically develop in chronically sun-exposed skin. It is well known that age spots are strongly related to chronic sun exposure and are associated with photodamage and an increased risk for skin cancer; however, the mechanisms underlying their development remain poorly understood. We used immunohistochemical analysis and microarray analysis to investigate the processes involved in their formation, focusing on specific markers associated with the functions and proliferation of melanocytes and keratinocytes. A total of 193 genes were differentially expressed in age spots, but melanocyte pigment genes were not among them. The increased expression of keratins 5 and 10, markers of basal and suprabasal keratinocytes, respectively, in age spots suggests that the increased proliferation of basal keratinocytes combined with the decreased turnover of suprabasal keratinocytes leads to the exaggerated formation of rete ridges in lesional epidermis which in turn disrupts the normal processing of melanin upwards from the basal layer. Based on our results, we propose a model for the development of age spots that explains the accumulation of melanin and the development of extensive rete ridges in those hyperpigmented lesions.


Assuntos
Lentigo/genética , Lentigo/metabolismo , Melaninas/metabolismo , Melanócitos , Envelhecimento da Pele/genética , Idoso , Citoproteção , Humanos , Queratina-10/genética , Queratina-5/genética , Queratinócitos/fisiologia , Lentigo/patologia , Melaninas/genética , Melanócitos/metabolismo , Melanócitos/patologia , Pessoa de Meia-Idade , Modelos Biológicos , Envelhecimento da Pele/patologia , Transcriptoma
2.
J Pathol ; 236(1): 17-29, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25488118

RESUMO

Human skin colour, ie pigmentation, differs widely among individuals, as do their responses to various types of ultraviolet radiation (UV) and their risks of skin cancer. In some individuals, UV-induced pigmentation persists for months to years in a phenomenon termed long-lasting pigmentation (LLP). It is unclear whether LLP is an indicator of potential risk for skin cancer. LLP seems to have similar features to other forms of hyperpigmentation, eg solar lentigines or age spots, which are clinical markers of photodamage and risk factors for precancerous lesions. To investigate what UV-induced molecular changes may persist in individuals with LLP, clinical specimens from non-sunburn-inducing repeated UV exposures (UVA, UVB or UVA + UVB) at 4 months post-exposure (short-term LLP) were evaluated by microarray analysis and dataset mining. Validated targets were further evaluated in clinical specimens from six healthy individuals (three LLP+ and three LLP-) followed for more than 9 months (long-term LLP) who initially received a single sunburn-inducing UVA + UVB exposure. The results support a UV-induced hyperpigmentation model in which basal keratinocytes have an impaired ability to remove melanin that leads to a compensatory mechanism by neighbouring keratinocytes with increased proliferative capacity to maintain skin homeostasis. The attenuated expression of SOX7 and other hemidesmosomal components (integrin α6ß4 and plectin) leads to increased melanosome uptake by keratinocytes and points to a spatial regulation within the epidermis. The reduced density of hemidesmosomes provides supporting evidence for plasticity at the epidermal-dermal junction. Altered hemidesmosome plasticity, and the sustained nature of LLP, may be mediated by the role of SOX7 in basal keratinocytes. The long-term sustained subtle changes detected are modest, but sufficient to create dramatic visual differences in skin colour. These results suggest that the hyperpigmentation phenomenon leading to increased interdigitation develops in order to maintain normal skin homeostasis in individuals with LLP.


Assuntos
Epiderme/metabolismo , Hemidesmossomos/metabolismo , Queratinócitos/metabolismo , Pigmentação da Pele/efeitos da radiação , Pele/metabolismo , Raios Ultravioleta/efeitos adversos , Células Cultivadas , Epiderme/efeitos da radiação , Hemidesmossomos/efeitos da radiação , Humanos , Queratinócitos/efeitos da radiação , Pele/efeitos da radiação , Neoplasias Cutâneas/metabolismo , Neoplasias Cutâneas/patologia , Tempo
3.
Exp Dermatol ; 23(10): 731-5, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25055985

RESUMO

Differences in visible skin pigmentation give rise to the wide variation of skin colours seen in racial/ethnic populations. Skin pigmentation is important not only from cosmetic and psychological points of view, but more importantly because of its implications for the risk of all types of skin cancers, on photoaging, etc. Despite differences in those parameters in Caucasian and Asian skin types, they are remarkably similar in their production and distribution of melanins, and the mechanism(s) underlying their different characteristics have remained obscure. In this study, we used microarray analysis of skin suction blisters to investigate molecular differences underlying the determination of pigmentation in various skin types, and we used immunohistochemistry to validate the expression patterns of several interesting targets that were identified. Intriguingly, Caucasian and Asian skins had highly similar gene expression patterns that differed significantly from the pattern of African skin. The results of this study suggest the dynamic interactions of different types of cells in human skin that regulate its pigmentation, reveal that the known pigmentation genes have a limited contribution and uncover a new array of genes, including NINL and S100A4, that might be involved in that regulation.


Assuntos
Povo Asiático/genética , População Negra/genética , Pigmentação da Pele/genética , População Branca/genética , Epiderme/metabolismo , Variação Genética , Humanos , Imuno-Histoquímica , Proteínas Associadas aos Microtúbulos/genética , Proteínas Nucleares/genética , Análise de Sequência com Séries de Oligonucleotídeos , Proteína A4 de Ligação a Cálcio da Família S100 , Proteínas S100/genética , Transcriptoma
4.
Proc Natl Acad Sci U S A ; 108(16): 6597-602, 2011 Apr 19.
Artigo em Inglês | MEDLINE | ID: mdl-21460252

RESUMO

The identification of genes that participate in melanomagenesis should suggest strategies for developing therapeutic modalities. We used a public array comparative genomic hybridization (CGH) database and real-time quantitative PCR (qPCR) analyses to identify the AMP kinase (AMPK)-related kinase NUAK2 as a candidate gene for melanomagenesis, and we analyzed its functions in melanoma cells. Our analyses had identified a locus at 1q32 where genomic gain is strongly associated with tumor thickness, and we used real-time qPCR analyses and regression analyses to identify NUAK2 as a candidate gene at that locus. Associations of relapse-free survival and overall survival of 92 primary melanoma patients with NUAK2 expression measured using immunohistochemistry were investigated using Kaplan-Meier curves, log rank tests, and Cox regression models. Knockdown of NUAK2 induces senescence and reduces S-phase, decreases migration, and down-regulates expression of mammalian target of rapamycin (mTOR). In vivo analysis demonstrated that knockdown of NUAK2 suppresses melanoma tumor growth in mice. Survival analysis showed that the risk of relapse is greater in acral melanoma patients with high levels of NUAK2 expression than in acral melanoma patients with low levels of NUAK2 expression (hazard ratio = 3.88; 95% confidence interval = 1.44-10.50; P = 0.0075). These data demonstrate that NUAK2 expression is significantly associated with the oncogenic features of melanoma cells and with the survival of acral melanoma patients. NUAK2 may provide a drug target to suppress melanoma progression. This study further supports the importance of NUAK2 in cancer development and tumor progression, while AMPK has antioncogenic properties.


Assuntos
Movimento Celular , Regulação Enzimológica da Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Melanoma/enzimologia , Melanoma/mortalidade , Proteínas de Neoplasias/biossíntese , Proteínas Serina-Treonina Quinases/biossíntese , Animais , Senescência Celular/genética , Intervalo Livre de Doença , Feminino , Técnicas de Silenciamento de Genes , Loci Gênicos/genética , Estudo de Associação Genômica Ampla , Humanos , Masculino , Melanoma/genética , Melanoma/patologia , Melanoma/terapia , Camundongos , Camundongos Nus , Proteínas de Neoplasias/genética , Proteínas Serina-Treonina Quinases/genética , Fase S/genética , Taxa de Sobrevida , Serina-Treonina Quinases TOR/genética , Serina-Treonina Quinases TOR/metabolismo
5.
Exp Dermatol ; 22(4): 266-71, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23528212

RESUMO

The diversity of human skin phenotypes and the ubiquitous exposure to ultraviolet radiation (UVR) underscore the need for a non-invasive tool to predict an individual's UVR sensitivity. We analysed correlations between UVR sensitivity, melanin content, diffuse reflectance spectroscopy (DR) and UVR-induced DNA damage in the skin of subjects from three racial/ethnic groups: Asian, black or African American and White. UVR sensitivity was determined by evaluating each subject's response to one minimal erythemal dose (MED) of UVR one day after the exposure. Melanin content was measured using DR and by densitometric analysis of Fontana-Masson staining (FM) in skin biopsies taken from unexposed areas. An individual's UVR sensitivity based on MED was highly correlated with melanin content measured by DR and by FM. Therefore, a predictive model for the non-invasive determination of UVR sensitivity using DR was developed. The MED precision was further improved when we took race/ethnicity into consideration. The use of DR serves as a tool for predicting UVR sensitivity in humans that should be invaluable for determining appropriate UVR doses for therapeutic, diagnostic and/or cosmetic devices.


Assuntos
Melaninas/metabolismo , Pele/metabolismo , Pele/efeitos da radiação , Raios Ultravioleta/efeitos adversos , Adulto , Dano ao DNA , Eritema/etiologia , Eritema/metabolismo , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Modelos Biológicos , Tolerância a Radiação , Pigmentação da Pele/efeitos da radiação , Análise Espectral/métodos
6.
J Cell Sci ; 123(Pt 18): 3102-11, 2010 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-20736300

RESUMO

Interactions between melanocytes and neighboring cells in the skin are important in regulating skin color in humans. We recently demonstrated that the less pigmented and thicker skin on the palms and soles is regulated by underlying fibroblasts in those areas, specifically via a secreted factor (DKK1) that modulates Wnt signaling. In this study, we tested the hypothesis that dermal fibroblasts regulate the constitutive skin color of individuals ranging from very light to very dark. We used microarray analysis to compare gene expression patterns in fibroblasts derived from lighter skin types compared to darker skin types, with a focus on secreted proteins. We identified a number of genes that differ dramatically in expression and, among the expressed proteins, neuregulin-1, which is secreted by fibroblasts derived from dark skin, effectively increases the pigmentation of melanocytes in tissue culture and in an artificial skin model and regulates their growth, suggesting that it is one of the major factors determining human skin color.


Assuntos
Melanócitos/metabolismo , Neuregulina-1/metabolismo , Pigmentação da Pele , Pele/metabolismo , Adulto , Células Cultivadas , Fibroblastos/metabolismo , Regulação da Expressão Gênica , Humanos , Peptídeos e Proteínas de Sinalização Intercelular/genética , Peptídeos e Proteínas de Sinalização Intercelular/metabolismo , Neuregulina-1/genética
7.
Photodermatol Photoimmunol Photomed ; 28(4): 187-95, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23017171

RESUMO

BACKGROUND: The Food and Drug Administration has published guidelines for manufacturer-recommended exposure schedules for ultraviolet (UV) tanning, intended to limit acute and delayed damage from UV exposure. These guidelines recommend that exposure schedules be adjusted for skin phototype. However, it has been shown that the dose necessary to produce tanning is similar for phototypes 2-4. METHODS: We observed tanning in phototypes 2 and 3 from repeated UV exposures over a 5-week period. Pigmentation was evaluated visually, instrumentally, and through Fontana-Masson staining of biopsies. RESULTS: The resultant pigmentation was equal or greater in phototype 3 compared with phototype 2 - both visually and instrumentally - measured on day 31 of the exposure protocol. The amount of melanin measured in biopsies taken 24 h postexposure was also greater in phototype 3 compared with phototype 2. CONCLUSION: Published data on tanning in phototypes 4 and 5 support our findings that higher phototypes can develop pigmentation more efficiently than lower phototypes. Therefore, a universal exposure schedule (based on sensitivity of phototype 2) can be used for all phototypes that are expected to engage in indoor tanning. This approach will result in a reduction of the UV burden for skin phototypes 3 and above.


Assuntos
Pigmentação da Pele/efeitos da radiação , Pele/metabolismo , Banho de Sol , Raios Ultravioleta/efeitos adversos , Adulto , Relação Dose-Resposta à Radiação , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pele/patologia , Estados Unidos , United States Food and Drug Administration
8.
Proc Natl Acad Sci U S A ; 106(6): 1802-7, 2009 Feb 10.
Artigo em Inglês | MEDLINE | ID: mdl-19174519

RESUMO

The melanocortin-1 receptor (MC1R) is a key regulator of pigmentation in mammals and is tightly linked to an increased risk of skin cancers, including melanoma, in humans. Physiologically activated by alpha-melanocyte stimulating hormone (alphaMSH), MC1R function can be antagonized by a secreted factor, agouti signal protein (ASP), which is responsible for the lighter phenotypes in mammals (including humans), and is also associated with increased risk of skin cancer. It is therefore of great interest to characterize the molecular effects elicited by those MC1R ligands. In this study, we determined the gene expression profiles of murine melan-a melanocytes treated with ASP or alphaMSH over a 4-day time course using genome-wide oligonucleotide microarrays. As expected, there were significant reductions in expression of numerous melanogenic proteins elicited by ASP, which correlates with its inhibition of pigmentation. ASP also unexpectedly modulated the expression of genes involved in various other cellular pathways, including glutathione synthesis and redox metabolism. Many genes up-regulated by ASP are involved in morphogenesis (especially in nervous system development), cell adhesion, and extracellular matrix-receptor interactions. Concomitantly, ASP enhanced the migratory potential and the invasiveness of melanocytic cells in vitro. These results demonstrate the role of ASP in the dedifferentiation of melanocytes, identify pigment-related genes targeted by ASP and by alphaMSH, and provide insights into the pleiotropic molecular effects of MC1R signaling that may function during development and may affect skin cancer risk.


Assuntos
Proteína Agouti Sinalizadora/fisiologia , Diferenciação Celular , Perfilação da Expressão Gênica , Melanócitos/citologia , Receptor Tipo 1 de Melanocortina/metabolismo , Proteína Agouti Sinalizadora/farmacologia , Animais , Movimento Celular/efeitos dos fármacos , Suscetibilidade a Doenças , Regulação da Expressão Gênica/efeitos dos fármacos , Genômica , Ligantes , Camundongos , Análise de Sequência com Séries de Oligonucleotídeos , Pigmentação/efeitos dos fármacos , Pigmentação/genética , Transdução de Sinais , Neoplasias Cutâneas/etiologia , alfa-MSH/farmacologia
9.
FASEB J ; 24(3): 916-30, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19884326

RESUMO

Ectodomain shedding is a proteolytic mechanism by which a transmembrane protein is converted into a secreted form. Pmel17/gp100 is a melanocyte-specific membrane-bound glycoprotein that has amyloid characteristics and forms fibrillar structures in melanosomes after a complex sequence of post-translational processing and trafficking events, including cleavage by a furin-like proprotein convertase (PC). A secreted form of Pmel17 (termed sPmel17) was also thought to be released due to cleavage by a PC. We used multidisciplinary approaches to demonstrate that sPmel17 is released by ectodomain shedding at the juxtamembrane and/or intramembrane motif and to show that this is independent of cleavage by a PC. We further show that sPmel17 consists of 2 fragments linked by disulfide bonds and that the shedding is inhibited at low temperature but not by metalloproteinase inhibitors. Moreover, treatment with a phorbol ester or a calmodulin inhibitor induces Pmel17 shedding. We also refine the reactivity of HMB50 and NKI/beteb, 2 monoclonal antibodies commonly used as melanoma-specific markers. The fact that those antibodies require physically separated domains of Pmel17 sheds interesting light on its 3-dimensional conformation. We conclude that sPmel17 is released by regulated proteolytic ectodomain shedding.-Hoashi, T., Tamaki, K., Hearing, V. J. The secreted form of a melanocyte membrane-bound glycoprotein (Pmel17/gp100) is released by ectodomain shedding.


Assuntos
Melanócitos/metabolismo , Glicoproteínas de Membrana/metabolismo , Adenoviridae , Animais , Anticorpos Monoclonais/metabolismo , Calmodulina/antagonistas & inibidores , Linhagem Celular , Linhagem Celular Tumoral , Glicosilação , Células HeLa , Humanos , Immunoblotting , Imunoprecipitação , Melanócitos/efeitos dos fármacos , Glicoproteínas de Membrana/química , Glicoproteínas de Membrana/genética , Microscopia de Fluorescência , Ésteres de Forbol/farmacologia , Fosforilcolina/análogos & derivados , Fosforilcolina/farmacologia , Ácidos Polimetacrílicos/farmacologia , Pró-Proteína Convertases/metabolismo , Ligação Proteica/efeitos dos fármacos , Estrutura Terciária de Proteína/genética , Estrutura Terciária de Proteína/fisiologia , Coelhos , Azida Sódica/farmacologia , Sulfonamidas/farmacologia , Antígeno gp100 de Melanoma
10.
FASEB J ; 24(5): 1616-29, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20056711

RESUMO

Melanosomes are organelles specialized for the production of melanin pigment and are specifically produced by melanocytic cells. More than 150 pigmentation-related genes have been identified, including glycoprotein nonmetastatic melanoma protein b (GPNMB). A recent proteomics analysis revealed that GPNMB is localized in melanosomes, and GPNMB is a membrane-bound glycoprotein that shows high homology with a well-known melanosomal structural protein, Pmel17/gp100. In this study, we show that GPNMB is expressed in melanocytes of normal human skin, as well as in human melanoma cells. GPNMB is heavily glycosylated and is enriched in mature (stage III and IV) melanosomes in contrast to MART-1 and Pmel17, which are abundant in early (stage I and II) melanosomes. MART-1 and Pmel17 play critical roles in the maturation of early melanosomes; thus, we speculate that GPNMB might be important in the functions of late melanosomes, possibly their transport and/or transfer to keratinocytes. We also demonstrate that a secreted form of GPNMB is released by ectodomain shedding from the largely Golgi-modified form of GPNMB and that the PKC and Ca(2+) intracellular signaling pathways regulate that shedding. We conclude that GPNMB is a melanosomal protein that is released by proteolytic ectodomain shedding and might be a useful and specific histological marker of melanocytic cells.


Assuntos
Biomarcadores Tumorais/metabolismo , Melanócitos/metabolismo , Melanoma/metabolismo , Melanossomas/metabolismo , Glicoproteínas de Membrana/metabolismo , Neoplasias Cutâneas/metabolismo , Linhagem Celular Tumoral , Meios de Cultura/metabolismo , Epiderme/metabolismo , Complexo de Golgi/metabolismo , Células HeLa , Humanos , Melanoma/patologia , Estadiamento de Neoplasias , Estabilidade Proteica , Proteômica , Neoplasias Cutâneas/patologia , Antígeno gp100 de Melanoma
11.
FASEB J ; 23(3): 835-43, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18971261

RESUMO

Melanin is a common pigment in animals. In humans, melanin is produced in melanocytes, in retinal pigment epithelium (RPE) cells, in the inner ear, and in the central nervous system. Previously, we noted that human adipose tissue expresses several melanogenesis-related genes. In the current study, we confirmed the expression of melanogenesis-related mRNAs and proteins in human adipose tissue using real-time polymerase chain reaction and immunohistochemical staining. TYR mRNA signals were also detected by in situ hybridization in visceral adipocytes. The presence of melanin in human adipose tissue was revealed both by Fontana-Masson staining and by permanganate degradation of melanin coupled with liquid chromatography/ultraviolet/mass spectrometry determination of the pyrrole-2,3,5-tricarboxylic acid (PTCA) derivative of melanin. We also compared melanogenic activities in adipose tissues and in other human tissues using the L-[U-(14)C] tyrosine assay. A marked heterogeneity in the melanogenic activities of individual adipose tissue extracts was noted. We hypothesize that the ectopic synthesis of melanin in obese adipose may serve as a compensatory mechanism that uses its anti-inflammatory and its oxidative damage-absorbing properties. In conclusion, our study demonstrates for the first time that the melanin biosynthesis pathway is functional in adipose tissue.


Assuntos
Tecido Adiposo/metabolismo , Melaninas/biossíntese , Animais , Cromatografia Líquida/métodos , Regulação da Expressão Gênica/fisiologia , Cabelo/química , Humanos , Oxirredutases Intramoleculares/genética , Oxirredutases Intramoleculares/metabolismo , Espectrometria de Massas/métodos , Melaninas/análise , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/metabolismo , Camundongos , Oxirredutases/genética , Oxirredutases/metabolismo
12.
Chin Med J (Engl) ; 133(10): 1231-1238, 2020 May 20.
Artigo em Inglês | MEDLINE | ID: mdl-32433056

RESUMO

Current treatment of vitiligo is still a great challenge, since most cases of vitiligo have variable re-pigmentation outcomes due to their unpredictable responses to existing therapeutic regimens. There is an urgent need to identify this re-pigmentation process and to develop novel therapies. This review illustrates the most current research and latest understanding of vitiligo skin re-pigmentation and related regulatory mechanisms. Literature was collected from PubMed until January 2020, using the search terms including "vitiligo," "re-pigmentation," "phototherapy," "narrow-band ultraviolet B, " "excimer," "fractional carbon dioxide laser," and "melanocyte stem cells." Literature was mainly derived from English articles. Article type was not limited. Emerging evidence suggests that patients with vitiligo present various re-pigmentation patterns following ultraviolet B phototherapy, which relies on different cell reservoirs from the perilesional margins and/or from uninvolved hair follicles to replenish functional melanocytes that are lost in vitiliginous skin. The following events are likely to be involved in this re-pigmentation process, including: 1) changes in the paracrine secretion and distribution of transforming growth factor-ß1 in the bulge area and in the epidermis; 2) the enhanced transfer of dermal pro-melanogenic growth factors to the epidermis; and 3) the induction of a C-X-C motif chemokine ligand (CXCL) 12-enriched micro-environment that efficiently recruits CXCR4- or CXCR7-positive melanocytes. Ongoing studies on the cellular and molecular events underlying vitiligo re-pigmentation will help design new therapeutic strategies to improve treatment outcomes.


Assuntos
Vitiligo , Epiderme , Folículo Piloso , Humanos , Melanócitos , Pigmentação da Pele
13.
J Cell Physiol ; 220(3): 640-54, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19452503

RESUMO

The melanocortin 1 receptor (MC1R), a Gs protein-coupled receptor (GPCR) expressed in melanocytes, is a major determinant of skin pigmentation and phototype. MC1R activation stimulates melanogenesis and increases the ratio of black, strongly photoprotective eumelanins to reddish, poorly photoprotective pheomelanins. Several MC1R alleles are associated with red hair, fair skin, increased sensitivity to ultraviolet radiation (the RHC phenotype) and increased skin cancer risk. Three highly penetrant RHC variants, R151C, R160W, and D294H are loss-of-function MC1R mutants with altered cell surface expression. In this study, we show that forward trafficking was normal for D294H. Conversely, export traffic was impaired for R151C, which accumulated in the endoplasmic reticulum (ER), and for R160W, which was enriched in the cis-Golgi. This is the first report of steady-state retention in a post-ER secretory compartment of a GPCR mutant found in the human population. Residues R151 and R160 are located in the MC1R second intracellular loop (il2). Two other mutations in il2, T157A preventing T157 phosphorylation and R162P disrupting a (160)RARR(163) motif, also caused intracellular retention. Moreover, T157 was phosphorylated in wild-type MC1R and a T157D mutation mimicking constitutive phosphorylation allowed normal traffic, and rescued the retention phenotype of R160W and R162P. Therefore, MC1R export is likely regulated by T157 phosphorylation and the (160)RARR(163) arginine-based motif functions as an ER retrieval signal. These elements are conserved in mammalian MC1Rs and in all five types of human melanocortin receptors. Thus, members of this GPCR subfamily might share common mechanisms for regulation of plasma membrane expression.


Assuntos
Membrana Celular/metabolismo , Retículo Endoplasmático/metabolismo , Complexo de Golgi/metabolismo , Cor de Cabelo , Melanócitos/metabolismo , Receptor Tipo 1 de Melanocortina/metabolismo , Neoplasias Cutâneas/metabolismo , Pigmentação da Pele , Motivos de Aminoácidos , Sequência de Aminoácidos , Linhagem Celular , Humanos , Dados de Sequência Molecular , Mutação , Fosforilação , Conformação Proteica , Transporte Proteico , Receptor Tipo 1 de Melanocortina/genética , Neoplasias Cutâneas/genética , Relação Estrutura-Atividade , Fatores de Tempo , Transfecção
14.
FASEB J ; 22(4): 1009-20, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17984176

RESUMO

The epidermis (containing primarily keratinocytes and melanocytes) overlies the dermis (containing primarily fibroblasts) of human skin. We previously reported that dickkopf 1 (DKK1) secreted by fibroblasts in the dermis elicits the hypopigmented phenotype of palmoplantar skin due to suppression of melanocyte function and growth via the regulation of two important signaling factors, microphthalmia-associated transcription factor (MITF) and beta-catenin. We now report that treatment of keratinocytes with DKK1 increases their proliferation and decreases their uptake of melanin and that treatment of reconstructed skin with DKK1 induces a thicker and less pigmented epidermis. DNA microarray analysis revealed many genes regulated by DKK1, and several with critical expression patterns were validated by reverse transcriptase-polymerase chain reaction and Western blotting. DKK1 induced the expression of keratin 9 and alpha-Kelch-like ECT2 interacting protein (alphaKLEIP) but down-regulated the expression of beta-catenin, glycogen synthase kinase 3beta, protein kinase C, and proteinase-activated receptor-2 (PAR-2), which is consistent with the expression patterns of those proteins in human palmoplantar skin. Treatment of reconstructed skin with DKK1 reproduced the expression patterns of those key proteins observed in palmoplantar skin. These findings further elucidate why human skin is thicker and paler on the palms and soles than on the trunk through topographical and site-specific differences in the secretion of DKK1 by dermal fibroblasts that affects the overlying epidermis.


Assuntos
Peptídeos e Proteínas de Sinalização Intercelular/metabolismo , Queratinócitos/metabolismo , Transdução de Sinais , Pigmentação da Pele , Proteínas Wnt/metabolismo , beta Catenina/metabolismo , Adulto , Proliferação de Células , Humanos , Imuno-Histoquímica , Queratina-9/metabolismo , Queratinócitos/citologia , Melaninas/metabolismo , Pessoa de Meia-Idade , Transfecção
15.
J Cell Biol ; 165(2): 275-85, 2004 Apr 26.
Artigo em Inglês | MEDLINE | ID: mdl-15117970

RESUMO

We investigated whether or not the topographic regulation of melanocyte differentiation is determined by mesenchymal-epithelial interactions via fibroblast-derived factors. The melanocyte density in palmoplantar human skin (i.e., skin on the palms and the soles) is five times lower than that found in nonpalmoplantar sites. Palmoplantar fibroblasts significantly suppressed the growth and pigmentation of melanocytes compared with nonpalmoplantar fibroblasts. Using cDNA microarray analysis, fibroblasts derived from palmoplantar skin expressed high levels of dickkopf 1 (DKK1; an inhibitor of the canonical Wnt signaling pathway), whereas nonpalmoplantar fibroblasts expressed higher levels of DKK3. Transfection studies revealed that DKK1 decreased melanocyte function, probably through beta-catenin-mediated regulation of microphthalmia-associated transcription factor activity, which in turn modulates the growth and differentiation of melanocytes. Thus, our results provide a basis to explain why skin on the palms and the soles is generally hypopigmented compared with other areas of the body, and might explain why melanocytes stop migrating in the palmoplantar area during human embryogenesis.


Assuntos
Diferenciação Celular/fisiologia , Divisão Celular/fisiologia , Células Epiteliais/metabolismo , Fibroblastos/fisiologia , Melanócitos/fisiologia , Mesoderma/metabolismo , Proteínas/metabolismo , Pele/citologia , Proteínas Adaptadoras de Transdução de Sinal , Adulto , Animais , Biomarcadores , Quimiocinas , Proteínas do Citoesqueleto/metabolismo , Proteínas de Ligação a DNA/metabolismo , Fibroblastos/citologia , Pé/anatomia & histologia , Perfilação da Expressão Gênica , Mãos/anatomia & histologia , Humanos , Peptídeos e Proteínas de Sinalização Intercelular , Melaninas/metabolismo , Melanócitos/citologia , Fator de Transcrição Associado à Microftalmia , Pessoa de Meia-Idade , Análise de Sequência com Séries de Oligonucleotídeos , Proteínas/genética , Transdução de Sinais/fisiologia , Pele/metabolismo , Pigmentação da Pele/fisiologia , Transativadores/metabolismo , Fatores de Transcrição/metabolismo , beta Catenina
16.
J Investig Dermatol Symp Proc ; 14(1): 73-5, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19675559

RESUMO

Dickkopf 1 (DKK1), an inhibitor of Wnt signaling, not only functions as a head inducer during development, but also regulates joint remodeling and bone formation, which suggests roles for DKK1 in the pathogenesis of rheumatoid arthritis and multiple myeloma. We recently demonstrated that levels of DKK1 in palmoplantar dermal fibroblasts are physiologically higher than those observed in non-palmoplantar dermal fibroblasts. Thus, the DKK1-rich mesenchyme in palmoplantar dermis affects the overlying epithelium and induces a palmoplantar phenotype in the epidermis. More specifically, DKK1 suppresses melanocyte function and growth through the regulation of microphthalmia-associated transcription factor (MITF) and beta-catenin. Furthermore, DKK1 induces the expression of keratin 9 and alpha-Kelch-like ECT2-interacting protein (alphaKLEIP) but downregulates the expression of beta-catenin, glycogen synthase kinase 3beta, protein kinase C, and proteinase-activated receptor-2 (PAR-2) in keratinocytes. Treatment of reconstructed skin with DKK1 reproduces the hypopigmentation and thickening of skin through Wnt/beta-catenin signaling. These studies elucidate why human palmoplantar skin is thicker and paler than non-palmoplantar skin through the secretion of DKK1 by fibroblasts that affect the overlying epidermis. Thus, DKK1 may be useful for reducing skin pigmentation and for thickening photo-aged skin and palmoplantar wounds caused by diabetes mellitus and rheumatic skin diseases.Journal of Investigative Dermatology Symposium Proceedings (2009) 14, 73-75; doi:10.1038/jidsymp.2009.4.


Assuntos
Peptídeos e Proteínas de Sinalização Intercelular/fisiologia , Pigmentação da Pele/fisiologia , Pele/anatomia & histologia , Fibroblastos/fisiologia , , Mãos , Humanos , Queratinócitos/fisiologia , Melanócitos/fisiologia , Modelos Biológicos , Transdução de Sinais , Fenômenos Fisiológicos da Pele
17.
J Investig Dermatol Symp Proc ; 14(1): 32-5, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19675550

RESUMO

The incidence of skin cancer, including cutaneous melanoma, has risen substantially in recent years, and epidemiological and laboratory studies show that UV radiation is a major causative factor of this increase. UV damage also underlies photoaging of the skin, and these deleterious effects of UV can be, in part, prevented in skin with higher levels of constitutive pigmentation. We review the clinical studies we have made in recent years regarding the rapid and the long-term responses of the pigmentary system in human skin to UV exposure.Journal of Investigative Dermatology Symposium Proceedings (2009) 14, 32-35; doi:10.1038/jidsymp.2009.10.


Assuntos
Pigmentação da Pele/efeitos da radiação , Raios Ultravioleta/efeitos adversos , Contagem de Células , Relação Dose-Resposta à Radiação , Humanos , Imuno-Histoquímica , Melaninas/metabolismo , Melanócitos/metabolismo , Melanócitos/patologia , Melanócitos/efeitos da radiação , Pele/metabolismo , Pele/patologia , Pele/efeitos da radiação , Fatores de Tempo
18.
Photochem Photobiol ; 85(4): 1032-7, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19320841

RESUMO

The increased popularity of commercially available three-dimensional human skin equivalents in recent years has allowed for assessment of melanogenesis modulated by compounds topically applied to the skin or directly incorporated from the medium. These skin equivalents provide a suitable model for elucidating the mechanisms of action of various factors that modulate skin pigmentation or other properties of the skin. As such, researchers need to objectively quantify cutaneous responses at the macroscopic level. A simple method to standardize macrophotography images is reported that can quantify cutaneous responses in human skin equivalents of Asian, Black or African American, and Caucasian or White racial/ethnic origin. Macrophotographs are analyzed using the Commission Internationale de l'Eclairage L*a*b* color space system in combination with a personal computer and image editing software. Pigmentation changes monitored over a 9 day period showed a high correlation with melanin content evaluated in Fontana-Masson-stained sections. These results indicate the feasibility of using a macrophotography setup in a sterile tissue culture environment to objectively assess in vitro cutaneous responses in human skin equivalents. This serves as an adjunct tool to biochemical and morphological methods to effectively quantify changes in pigmentation over time.


Assuntos
Fotografação/métodos , Pele/patologia , Humanos
19.
Biofactors ; 35(2): 193-9, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19449448

RESUMO

More than 150 genes have been identified that affect skin color either directly or indirectly, and we review current understanding of physiological factors that regulate skin pigmentation. We focus on melanosome biogenesis, transport and transfer, melanogenic regulators in melanocytes, and factors derived from keratinocytes, fibroblasts, endothelial cells, hormones, inflammatory cells, and nerves. Enzymatic components of melanosomes include tyrosinase, tyrosinase-related protein 1, and dopachrome tautomerase, which depend on the functions of OA1, P, MATP, ATP7A, and BLOC-1 to synthesize eumelanins and pheomelanins. The main structural component of melanosomes is Pmel17/gp100/Silv, whose sorting involves adaptor protein 1A (AP1A), AP1B, AP2, and spectrin, as well as a chaperone-like component, MART-1. During their maturation, melanosomes move from the perinuclear area toward the plasma membrane. Microtubules, dynein, kinesin, actin filaments, Rab27a, melanophilin, myosin Va, and Slp2-a are involved in melanosome transport. Foxn1 and p53 up-regulate skin pigmentation via bFGF and POMC derivatives including alpha-MSH and ACTH, respectively. Other critical factors that affect skin pigmentation include MC1R, CREB, ASP, MITF, PAX3, SOX9/10, LEF-1/TCF, PAR-2, DKK1, SCF, HGF, GM-CSF, endothelin-1, prostaglandins, leukotrienes, thromboxanes, neurotrophins, and neuropeptides. UV radiation up-regulates most factors that increase melanogenesis. Further studies will elucidate the currently unknown functions of many other pigment genes/proteins. (c) 2009 International Union of Biochemistry and Molecular Biology, Inc.


Assuntos
Pigmentação da Pele/fisiologia , Animais , Transporte Biológico , Fibroblastos , Humanos , Queratinócitos/metabolismo , Melanócitos/metabolismo , Melanossomas/metabolismo
20.
Int J Mol Sci ; 10(10): 4428-4434, 2009 Nov 20.
Artigo em Inglês | MEDLINE | ID: mdl-20057953

RESUMO

Pigmentation of the skin, hair and eyes is regulated by tyrosinase, the critical rate-limiting enzyme in melanin synthesis by melanocytes. Tyrosinase is degraded endogenously, at least in part, by the ubiquitin proteasome system (UPS). Several types of inherited hypopigmentary diseases, such as oculocutaneous albinism and Hermansky-Pudlak syndrome, involve the aberrant processing and/or trafficking of tyrosinase and its subsequent degradation which can occur due to the quality-control machinery. Studies on carbohydrate modifications have revealed that tyrosinase in the endoplasmic reticulum (ER) is proteolyzed via ER-associated protein degradation and that tyrosinase degradation can also occur following its complete maturation in the Golgi. Among intrinsic factors that regulate the UPS, fatty acids have been shown to modulate tyrosinase degradation in contrasting manners through increased or decreased amounts of ubiquitinated tyrosinase that leads to its accelerated or decelerated degradation by proteasomes.


Assuntos
Complexo de Endopeptidases do Proteassoma/metabolismo , Pigmentação da Pele/fisiologia , Animais , Retículo Endoplasmático/enzimologia , Retículo Endoplasmático/metabolismo , Humanos , Melaninas/biossíntese , Melanócitos/metabolismo , Melanócitos/efeitos da radiação , Raios Ultravioleta
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA